Bortezomib and Docetaxel in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Clinical trial NCT00425750 · COMPLETED
Trial details
- NCT number
- NCT00425750
- Sponsor
- Vanderbilt-Ingram Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2009-06-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.